At its annual meeting of more than 10,000 financial representatives and staff members today, Northwestern Mutual announced its new multi-year philanthropic program to fight childhood cancer. The effort, through the Northwestern Mutual Foundation, builds upon the company’s legacy of helping children and families. It leverages Northwestern Mutual’s field force throughout the country to implement a range of community events and programs to raise awareness and money for pediatric cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53645-northwestern-mutual-philanthropic-campaign-pediatric-cancer-research
Marriott Hotels & Resorts, the signature brand of Marriott International (NYSE:MAR), renowned for its expertise in hosting meetings, is “re-imagining” the traditional small meeting to become a collaborative work experience that will promote creativity and innovation. Inspired by the work styles of Gen X and Gen Y, Marriott Hotels & Resorts has exclusively partnered with Steelcase, the leader in workspace design, and launched today Workspring at Marriott. Redmond Marriott Town Center, near Seattle, is the first hotel to offer the small meetings suite.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58273-marriott-hotels-resorts-workspring-at-marriott-small-meetings-suite
Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) today presented interim findings from its BEST (Blastocyst Euploid Selective Transfer) trial, the first well-controlled clinical trial comparing in vitro fertilization (IVF) pregnancy rates in a group of women receiving a single embryo transfer (SET) with comprehensive chromosome screening (CCS) with a group receiving traditional morphology-based double embryo transfer (DET). The findings were presented at the American Society for Reproductive Medicine 68th Annual Meeting in San Diego, October 20-24, 2012.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58883-rmanj-best-trial-results-ivf-pregnancy-rates-women-asrm-annual-meeting
Notorious pirates of the sea known for their ruthlessness and cunning to obtain that which satisfies their eternal quest for gold, treasures of wonderment and delight, unseen fortunes only whispered in folklore by the lips of the unfortunate souls who had dared to utter a word of such riches of the deep before meeting with their tragic fate are now in hot pursuit of the fairest treasure told by the tongues of the silenced with their dying breaths.
ELENA HOUSE, the fairest maiden of the sea is now being pursued by the evil rogues who have claimed the ocean to be their own trophy for the taking as they plunder and blunder throughout the high seas to capture and imprison she who they believe will soon to be their damsel of delights.
Little do our sea bearing proprietors of possessions know that the fair maiden is actually ELENA HOUSE AKA \
BOMBAY SAPPHIRE®, the world’s fastest-growing major gin brand by volume and value, is proud to announce that experienced distiller Nik Fordham has been appointed in the position of Master Distiller. Nik will oversee production for the brand and will lead its unique distillation process at the, currently under construction, Bombay Sapphire Distillery in Laverstoke Mill, Hampshire, England, due to open later this year. In addition to crafting the iconic gin and managing its production team, he will be responsible for the quality assurance for Bombay Sapphire gin, meeting the exacting standards of the brand’s well-known flavour profile and consistent quality in each bottle.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58717-bombay-sapphire-appoints-master-distiller
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
The 11th conference of the Eurasian Media Forum (EAMF) will take place in Astana on 25 and 26 April 2013.
This will be the Forum’s second meeting in the capital of Kazakhstan. It moved here for the first time last October, after a decade of annual conferences in Almaty, the country’s commercial hub.
Dariga Nazarbayeva, the Forum’s founder and chair of the Organising Committee, will welcome delegates old and new – political analysts, economists and media specialists – to two days of debate on the most pressing issues affecting East-West relations.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58721-eurasian-media-forum-meet-in-kazakhstan
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.2 In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts from across Europe highlight the current deficiencies in the management of CDI and outline the steps that are needed to address them.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60637-astellas-report-diagnosis-management-CDI
Extending its award-winning “Learn the Signs” campaign, Autism Speaks – the world’s leading autism science and advocacy organization – today joined the Ad Council, along with partner agencies BBDO New York and LatinWorks, to announce the launch of a new series of public service advertisements (PSAs) designed to reach African American and Hispanic parents. According to research, children in these communities are often diagnosed later than the average. The PSAs, which are being distributed to media outlets nationwide this week, show some of the early signs of autism and encourage parents to take immediate action if their child is not meeting standard developmental milestones.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61698-ad-council-and-autism-speaks-launch-psa-campaign
Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
To promote the science behind obesity prevention and treatment, The Obesity Society (TOS) and the American Society for Metabolic and Bariatric Surgery (ASMBS) are combining resources to host the world’s pre-eminent meeting on obesity, ObesityWeek(SM) 2013, Nov. 11-16, at the Georgia World Congress Center in Atlanta, Georgia. For the first time, both organizations will co-locate their respective annual meetings under one roof for the most comprehensive agenda in obesity research, treatment and prevention.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55494-tos-and-asmbs-host-obesity-week-2013
